Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: BriBear who wrote (3687)	1/28/1998 1:41:00 PM
From: JOHN W.	Respond to of 6136

Short interst up 12% as of 1/15/98.

To: BriBear who wrote (3687)	1/28/1998 1:43:00 PM
From: JOHN W.	Respond to of 6136

Subject: Short interest. Date: Wed, Jan 28, 1998 10:41 EST From: RRanney Message-id: <19980128154101.KAA14174@ladder03.news.aol.com> Short interest in AGPH as of 1/15/98 vs. 12/15/97: 7,759,404 vs. 6,903,411. So current short interest is about 26% of the shares outstanding. This is significant, in my opinion. It is getting to the point that, were I a person who believed that AGPH was overpriced and due for a fall, I would probably NOT pick AGPH to short, just becasuse of this very high short position relative to shares outstanding. Shorts increased by about 856,000 shares in last month. So they are not giving up, nor was there much covering of short positions when AGPH got down to 28 - 29 area. Only time will tell who is right in this stock, the longs or the shorts. As noted before on this board, I am long AGPH, and expecting ever increasing earnings from Viracept in the next several years. RR